Application Note

Application Note: Evaluation Of Process And Formulation Parameters On The Production Of Nanosuspensions

Source: Cirrus Pharmaceuticals, Inc.
The objectives of this study were to assess the Cosmo® Couette Perl Mill® with regards to: evaluating select formulation and process parameters on the production of prednisolone nanosuspension, the feasibility of nanosizing Carbamazepine, and contaminants leaching from the mill. Submitted by Cirrus Pharmaceuticals
access the Application Note!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests: